ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway
Abstract Background: Despite advancements in thyroid cancer (THCA) treatment, the prognosis for advanced cases remains poor. Cellular senescence is crucial…
Bowen Shi
Evaluation of Pan-Cancer Immune Heterogeneity Based on DNA Methylation
Abstract Background/Objectives: The heterogeneity of the tumor immune microenvironment is a key determinant of tumor oncogenesis. This study aims to…
Resting State Brain Networks under Inverse Agonist versus Complete Knockout of the Cannabinoid Receptor 1
Abstract The cannabinoid receptor 1 (CB1) is famous as the target of Δ9-tetrahydrocannabinol (THC), which is the active ingredient of…